Breaking News Instant updates and real-time market news.

IQV

Iqvia

$131.81

0.16 (0.12%)

07:13
02/14/19
02/14
07:13
02/14/19
07:13

Iqvia sees Q1 EPS $1.48-$1.53, consensus $1.49

Sees Q1 revenue $2.6B-$2.68, consensus $2.66B.

  • 14

    Feb

IQV Iqvia
$131.81

0.16 (0.12%)

01/11/19
GSCO
01/11/19
UPGRADE
Target $151
GSCO
Conviction Buy
Iqvia upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Robert Jones added Iqvia Holdings (IQ) to his firm's Americas Conviction List while keeping a Buy rating on the shares. The analyst lowered his price target for the shares to $151 from $152. He sees "several drivers of upside" in 2019 against a "very healthy" industry backdrop. Iqvia's backlog growth along with an industry leading book-to-bill indicate its offering is resonating in the market, Jones tells investors in a research note. He believes the company's upcoming commentary accompanying 2019 guidance could serve as a potential catalyst for the shares. Jones is also positive on shares of Icon (ICLR).
01/18/19
JEFF
01/18/19
UPGRADE
Target $150
JEFF
Buy
Iqvia upgraded to Buy from Hold at Jefferies
Jefferies analyst David Windley upgraded Iqvia to Buy and raised his price target for the shares to $150 from $136.
01/18/19
JEFF
01/18/19
UPGRADE
Target $150
JEFF
Buy
Jefferies upgrades Iqvia to Buy after encouraging CRO survey
Jefferies analyst David Windley upgraded Iqvia to Buy from Hold and raised his price target for the shares to $150 from $136. The analyst says the results from his firm's annual contract research organization survey show accelerating research and development spending, continued rise in outsourcing, and a "notable rise" in preference for global CROs over niche, private players. These results bode positively for growth in 2019 and beyond, Windley tells investors in a research note. He cites improving positive CRO feedback both in the survey and channel checks for his upgrade of Iqvia. The company has done a commendable job of upping the sales and operational intensity of its business as well as developing and launching integrated application platforms, says Windley.
01/18/19
01/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Edwards Lifesciences (EW) upgraded to Buy from Neutral at BofA/Merrill with analyst Bob Hopkins saying he expects Edwards' multiple to move higher as investors digest upcoming pipeline readouts for Low Risk Aortic and Mitral Repair over the next five months. 2. Iqvia (IQV) upgraded to Buy from Hold at Jefferies with analyst David Windley saying the results from his firm's annual contract research organization survey show accelerating research and development spending, continued rise in outsourcing, and a "notable rise" in preference for global CROs over niche, private players. 3. Arista Networks (ANET) upgraded to Buy from Neutral at Nomura Instinet wih analyst Jeffrey Kvaal saying he views the recent pullback in shares as a buying opportunity and he expects "strong" Q4 results and "robust" growth in 2019. 4. Chevron (CVX) upgraded to Buy from Neutral at UBS with analyst Jon Rigby saying the recent pullback in oil prices has presented a buying opportunity in the shares. 5. Sportsman's Warehouse (SPWH) upgraded to Overweight from Neutral at Piper Jaffray with analyst Peter Keith saying the company is "poised for substantially better fundamentals" while the shares trade at the "lowest valuation within our coverage universe." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

GM

General Motors

$39.67

0.04 (0.10%)

12:23
02/22/19
02/22
12:23
02/22/19
12:23
Hot Stocks
GM says over 1,500 employees volunteered to transfer to other U.S. locations »

General Motors said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

GM

General Motors

$39.66

0.03 (0.08%)

12:21
02/22/19
02/22
12:21
02/22/19
12:21
Hot Stocks
GM extends production at Detroit/Hamtramck into January 2020 »

GM said it has notified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

NWSA

News Corp.

$13.04

0.25 (1.95%)

12:20
02/22/19
02/22
12:20
02/22/19
12:20
Options
Notable print in News Corp puts »

Notable print in News…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
02/22/19
02/22
12:17
02/22/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
02/22/19
02/22
12:16
02/22/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$50.60

0.14 (0.28%)

, FOXA

21st Century Fox

$50.89

0.15 (0.30%)

12:14
02/22/19
02/22
12:14
02/22/19
12:14
Periodicals
Fox removes Jussie Smollett from last two episodes of 'Empire' season, WSJ says »

Producer's of Fox…

FOX

21st Century Fox

$50.60

0.14 (0.28%)

FOXA

21st Century Fox

$50.89

0.15 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

12:13
02/22/19
02/22
12:13
02/22/19
12:13
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened with modest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$7.70

-0.26 (-3.27%)

12:05
02/22/19
02/22
12:05
02/22/19
12:05
Periodicals
JAMA editorial says DBV trial results 'not easy to interpret' »

In an editorial published…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$11.15

0.12 (1.09%)

12:05
02/22/19
02/22
12:05
02/22/19
12:05
Options
GameStop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTN

Union Acquisition Corp

$5.89

-1.44 (-19.65%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Union Acquisition Corp falls -17.3% »

Union Acquisition Corp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

TDS

Telephone and Data

$32.14

-4.55 (-12.40%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Telephone and Data falls -12.5% »

Telephone and Data is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

DPLO

Diplomat Pharmacy

$7.65

-5.81 (-43.16%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Diplomat Pharmacy falls -42.9% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

PBI

Pitney Bowes

$8.25

1.225 (17.45%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Pitney Bowes rises 17.4% »

Pitney Bowes is up 17.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    Mar

SWM

Schweitzer-Mauduit

$41.20

6.51 (18.77%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Schweitzer-Mauduit rises 19.0% »

Schweitzer-Mauduit is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 28

    Mar

W

Wayfair

$153.23

36.09 (30.81%)

12:00
02/22/19
02/22
12:00
02/22/19
12:00
Hot Stocks
Wayfair rises 30.9% »

Wayfair is up 30.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

CAG

Conagra Brands

$23.13

-0.95 (-3.95%)

11:55
02/22/19
02/22
11:55
02/22/19
11:55
Options
ConAgra put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
02/22/19
02/22
11:55
02/22/19
11:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

11:55
02/22/19
02/22
11:55
02/22/19
11:55
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology &…

TKR

Timken

$43.82

0.41 (0.94%)

11:51
02/22/19
02/22
11:51
02/22/19
11:51
Conference/Events
Timken management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

KPTI

Karyopharm

$8.97

0.01 (0.11%)

11:50
02/22/19
02/22
11:50
02/22/19
11:50
Recommendations
Karyopharm analyst commentary  »

H.C. Wainwright sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 06

    Apr

JEC

Jacobs Engineering

$74.22

0.45 (0.61%)

11:48
02/22/19
02/22
11:48
02/22/19
11:48
Conference/Events
Jacobs Engineering management to meet with KeyBanc »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 12

    Mar

TCDA

Tricida

$23.11

0.84 (3.77%)

11:46
02/22/19
02/22
11:46
02/22/19
11:46
Initiation
Tricida initiated  »

Tricida initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$109.87

-1.89 (-1.69%)

11:45
02/22/19
02/22
11:45
02/22/19
11:45
Options
UPS call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

11:45
02/22/19
02/22
11:45
02/22/19
11:45
General news
More from Williams: the Phillips Curve needs to be taken seriously »

More from Williams: the…

OCUL

Ocular Therapeutix

$4.22

0.61 (16.90%)

11:37
02/22/19
02/22
11:37
02/22/19
11:37
Hot Stocks
Ocular Therapeutix higher after pricing $37.5M in convertible notes »

Shares of Ocular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.